Method for producing bacterial cellulose membrane capsule, bacterial cellulose membrane capsule, and pharmaceutical composition
The method forms a spherical bacterial cellulose membrane by culturing a granular gel with target particles in a hydrophobic medium, addressing the encapsulation challenge of larger particles and ensuring bacterial growth, resulting in stable encapsulation.
Patent Information
- Application Number
- JP2020137078
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-10-18
- Filing Date
- 2020-08-14
- Publication Date
- 2024-11-14
- Estimated Expiration
- 2040-08-14
AI Technical Summary
Existing methods struggle to encapsulate particles larger than 1 μm within hollow spherical bacterial cellulose membranes due to the limitations of the three-dimensional network structure, and the use of dispersion stabilizers inhibits bacterial growth.
A method involving the formation of a granular gel with target particles, culturing in a hydrophobic medium to create a spherical bacterial cellulose membrane, and dissolving the gel to encapsulate particles, while avoiding the use of stabilizers that hinder bacterial growth.
Enables the production of bacterial cellulose membrane capsules that effectively encapsulate particles larger than 1 μm, maintaining bacterial growth and providing a stable encapsulation mechanism.
Smart Images

Figure 0007583430000001 
Figure 0007583430000002 
Figure 0007583430000003
Abstract
Description
[Technical field]
[0001] The present invention relates to a method for producing a bacterial cellulose film capsule, a bacterial cellulose film capsule, and a pharmaceutical composition. [Background technology]
[0002] The fact that microorganisms produce cellulose was reported by A. J. Brown more than 100 years ago. Cellulose produced by microorganisms is generally called bacterial cellulose or biocellulose.
[0003] Cellulose produced by microorganisms (hereafter referred to as "bacterial cellulose") is known to have excellent properties not found in plant-derived cellulose. For example, plant-derived cellulose generally contains impurities such as lignin and hemicellulose. In contrast, bacterial cellulose contains few impurities and is composed almost entirely of pure cellulose. Furthermore, bacterial cellulose has high added-value properties as a substance, such as a fiber width that is said to be 1 / 100 to 1 / 1000 of the fiber width of plant cellulose, a high Young's modulus due to the strength of hydrogen bonds and planar orientation, and the ability to form liquid crystals.
[0004] Taking advantage of these characteristics of bacterial cellulose, various researches on its use are being conducted in the industrial and medical fields. To put such researches on its use into practical use, it is necessary to obtain bacterial cellulose in various shapes. The shape of bacterial cellulose is usually determined by the shape of the container used for culturing cellulose-producing bacteria. For this reason, it has been difficult to produce hollow spherical bacterial cellulose in the past. However, the present inventors have succeeded in producing hollow spherical bacterial cellulose membranes by forming culture droplets containing cellulose-producing bacteria in a hydrophobic medium and culturing them (Patent Document 1). [Prior art documents] [Patent documents]
[0005] [Patent Document 1] JP 2014-121314 A Summary of the Invention [Problem to be solved by the invention]
[0006] The bacterial cellulose membrane described in Patent Document 1 is composed of a gel membrane made of a three-dimensional mesh structure of cellulose fibers. Particles smaller than the pore size of the three-dimensional mesh structure can pass through the three-dimensional mesh structure and move into the space inside the hollow spherical bacterial cellulose membrane according to Fick's diffusion model, but particles with a particle size of 1 μm or more cannot pass through the three-dimensional mesh structure. Therefore, it was not possible to produce a spherical bacterial cellulose membrane containing particles with a particle size of 1 μm or more. On the other hand, in the method described in Patent Document 1, it is also possible to disperse particles in a culture solution of cellulose-producing bacteria. However, it is difficult to stably disperse particles without using a dispersion stabilizer such as a surfactant, and the growth of cellulose-producing bacteria is inhibited when a dispersion stabilizer is used. Therefore, the method of dispersing particles in a culture solution makes it impossible to encapsulate particles with a diameter of 1 μm or more in a hollow spherical bacterial cellulose membrane.
[0007] Therefore, an object of the present invention is to provide a method for producing a bacterial cellulose membrane capsule capable of encapsulating particles having a diameter of 1 μm or more, a bacterial cellulose membrane capsule produced by said method, and a pharmaceutical composition containing said bacterial cellulose membrane capsule. [Means for solving the problem]
[0008] The present invention includes the following aspects. [1] A method for producing bacterial cellulose membrane capsules, comprising: step A of preparing a granular gel containing particles with a diameter of 1 μm or more; step B of preparing culture droplets of a cellulose-producing bacterium containing the granular gel; step C of culturing the culture droplets in a hydrophobic medium and forming a bacterial cellulose membrane at the interface between the culture droplets and the hydrophobic medium to obtain spherical bacterial cellulose membranes encapsulating the granular gel; and step D of dissolving the granular gel encapsulated in the spherical bacterial cellulose membranes. [2] The method for producing the bacterial cellulose membrane capsule described in [1], further comprising a step E of removing the hydrophobic medium from the spherical bacterial cellulose membrane. [3] The method for producing a bacterial cellulose membrane capsule according to [1] or [2], further comprising a step F of removing the cellulose-producing bacteria from the spherical bacterial cellulose membrane. [4] A bacterial cellulose membrane capsule comprising a spherical bacterial cellulose membrane and a particle having a particle diameter of 1 μm or more, the particle being present in an internal space partitioned by the spherical bacterial cellulose membrane. [5] The bacterial cellulose membrane capsule according to [4], wherein the particles having a diameter of 1 μm or more are selected from the group consisting of adsorbents and enzyme immobilization carriers. [6] A pharmaceutical composition comprising the bacterial cellulose membrane capsule described in [4] or [5]. [7] A pharmaceutical composition for treating or preventing uremia, comprising the bacterial cellulose membrane capsule according to [5], wherein the particles having a diameter of 1 μm or more are activated carbon. [8] A pharmaceutical composition for treating or preventing hyperkalemia, comprising the bacterial cellulose membrane capsule described in [5], wherein the particles with a diameter of 1 μm or more are a potassium adsorbent. [9] A pharmaceutical composition for treating or preventing an enzyme deficiency, comprising the bacterial cellulose membrane capsule described in [5], wherein the particles with a particle diameter of 1 μm or more are enzyme immobilization carriers. Effect of the Invention
[0009] According to the present invention, there are provided a method for producing spherical bacterial cellulose membrane capsules capable of encapsulating particles having a particle diameter of 1 μm or more, particle-encapsulating spherical bacterial cellulose membrane capsules produced by said method, and a pharmaceutical composition containing said bacterial cellulose membrane capsules. [Brief description of the drawings]
[0010] [Figure 1] FIG. 2 is a diagram illustrating a method for producing a bacterial cellulose membrane capsule according to one embodiment of the present invention. [Diagram 2] FIG. 2 is a diagram illustrating a method for producing a bacterial cellulose membrane capsule according to one embodiment of the present invention. [Diagram 3] 1 shows the bacterial cellulose membrane capsules encapsulating glass beads prepared in Example 1. (A) is a photograph taken from directly above, and (B) is a photograph taken from the side. [Figure 4] (A) shows the appearance of a bacterial cellulose membrane dried by supercritical drying. (B) shows an FE-SEM image of the bacterial cellulose membrane aerogel. [Diagram 5] 3 shows the cosmetic glitter-encapsulated bacterial cellulose membrane capsules prepared in Example 2. [Figure 6] 1 shows the fluorescent particle-encapsulated alginate gel particles prepared in Example 3. (A) is an optical microscope photograph, and (B) is a fluorescent microscope photograph. [Figure 7] 3 shows bacterial cellulose membrane capsules encapsulating fluorescent particles prepared in Example 3. [Figure 8] The results of investigating the permeability of fluorescent particles through bacterial cellulose membranes are shown. [Figure 9] The figures show the activated carbon-containing bacterial cellulose membrane capsules prepared in Examples 4 and 5. (A) is a photograph of an activated carbon-containing bacterial cellulose membrane capsule encapsulating activated carbon with a diameter of 0.3 to 0.8 mm. (B) is a photograph of an activated carbon-containing bacterial cellulose membrane capsule encapsulating activated carbon with a diameter of 6.0 μm. [Figure 10]1 shows the results of an indole adsorption test using the activated carbon-containing bacterial cellulose membrane capsule of Example 5. [Figure 11] FIG. 1 is a schematic diagram showing the adsorption mechanism of uremia causative substances by activated carbon-containing bacterial cellulose membrane capsules. [Figure 12] 1 shows the bacterial cellulose membrane capsules containing a potassium adsorbent prepared in Example 6. [Figure 13] 1 shows bacterial cellulose membrane capsules encapsulating peroxidase-immobilized chitosan beads prepared in Example 7. [Figure 14] FIG. 1 is a schematic diagram showing the mechanism of enzyme-substrate reaction using bacterial cellulose membrane capsules encapsulating enzyme-immobilized beads. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0011] [Method of manufacturing bacterial cellulose membrane capsules] In one embodiment, the present invention provides a method for producing bacterial cellulose membrane capsules. The method for producing bacterial cellulose membrane capsules in this embodiment includes the steps of: Step A: preparing a granular gel containing particles with a particle diameter of 1 μm or more; Step B: preparing a culture droplet of a cellulose-producing bacterium containing the granular gel; Step C: culturing the culture droplet in a hydrophobic medium to form a bacterial cellulose membrane at the interface between the culture droplet and the hydrophobic medium to obtain a spherical bacterial cellulose membrane containing the granular gel; and Step D: dissolving the granular gel contained in the spherical bacterial cellulose membrane.
[0012] First Embodiment 1 is a diagram illustrating one embodiment of a method for producing bacterial cellulose membrane capsules. In the method of this embodiment, first, a particulate gel 20 is prepared containing particles 22 with a particle diameter of 1 μm or more (hereinafter, also referred to as "target particles") to be encapsulated in the bacterial cellulose membrane capsules (Step A). Next, the particulate gel 20 is immersed in a culture solution 30 containing cellulose-producing bacteria. With the culture solution 30 attached to the entire surface of the particulate gel 20, the particulate gel 20 is immersed in a hydrophobic medium 50 to produce a culture droplet D1 containing one particulate gel 20 (step B). Next, this is cultured to form a bacterial cellulose film at the interface between the culture droplet D1 and the hydrophobic medium 50. The culture is continued until the bacterial cellulose film covers the entire particulate gel 20, thereby obtaining a spherical bacterial cellulose film 31 encapsulating the particulate gel 20 (step C). Next, the particulate gel 20 encapsulated in the spherical bacterial cellulose film 31 is dissolved to obtain bacterial cellulose film capsules C1 encapsulating the target particles 22 (step D).
[0013] The manufacturing method of this embodiment produces bacterial cellulose membrane capsules C1 that are approximately the same size as the particulate gel 20. Since the size of the particulate gel 20 can be made relatively large, this method is suitable for encapsulating particles with a large particle size. Each step will be described in detail below.
[0014] (Process A) In step A, a granular gel containing particles having a particle size of 1 μm or more is prepared.
[0015] <Target particles> The target particles 22 are not particularly limited as long as they are particles with a particle diameter of 1 μm or more. The upper limit of the particle diameter of the target particles 22 is not particularly limited, but from the viewpoint of ease of forming the particulate gel 20, it can be, for example, 3 mm or less. The particle diameter of the target particles 22 is preferably 2.5 mm or less, more preferably 2 mm or less, even more preferably 1.5 mm or less, and particularly preferably 1 mm or less.
[0016] The material of the target particle 22 is not particularly limited, and can be appropriately selected according to the application of the bacterial cellulose membrane capsule. The target particle 22 may be an inorganic material or an organic material. The target particle 22 may be a cell such as a bacterial cell, a fungal cell, an animal cell, or a plant cell. Examples of the target particle 22 include, but are not limited to, various physiologically active substances, various pharmaceuticals, enzyme immobilized carriers (enzyme immobilized chitosan beads, etc.), adsorbents such as activated carbon and potassium adsorbents, dyes, pigments, dyes, fluorescent substances, various beads, cosmetic glitter, various beauty ingredients, various food additives, various food powders, various functional substances, physiologically active substance producing cells, pollutant decomposition bacteria, etc. It is preferable that the target particle 22 does not inhibit the cellulose producing ability of cellulose producing bacteria.
[0017] <Granular gel> The method for producing the particulate gel 20 containing the target particles 22 is not particularly limited. The particulate gel 20 can be produced, for example, by suspending the target particles 22 in a solution containing a gel-forming substance to produce a suspension of the target particles 22, and dropping the suspension into the gelation-inducing liquid 10. The term "gel-forming substance" refers to a substance that causes a solution containing the substance to gel under specific conditions. The term "gelation-inducing liquid" refers to a liquid that induces gelation of a solution containing a gel-forming substance.
[0018] The gel-forming substance is not particularly limited, and any substance known to form a gel can be used. The gel-forming substance is preferably one that does not inhibit the cellulose-producing ability of cellulose-producing bacteria. The gel-forming substance is preferably an organic polymer compound, and examples thereof include polysaccharides such as sodium alginate, xanthan gum, gellan gum, carrageenan, agarose, tamarind gum, roasted bean gum, chitosan, and hyaluronic acid; polyamino acids such as polyglutamic acid and polyaspartic acid; gelatin; collagen; synthetic polymers such as polyethylene glycol, carboxymethylcellulose, and hydroxyethylcellulose; and rigid polymers (stimulus-responsive sol-gel transition polymers) that can undergo sol-gel transition upon stimulation such as temperature, pH, and solute concentration, but are not limited thereto. Among the above-mentioned stimuli-responsive sol-gel transition polymers, examples of the temperature-responsive sol-gel transition polymer include poly(N-isopropylacrylamide derivatives), polyaspartic acid derivatives, and block copolymers of polyoxyethylene and polyoxypropylene. Examples of pH-responsive and solute concentration-responsive sol-gel transition polymers include poly(N-isopropylacrylamide derivatives).
[0019] The gelation-inducing liquid may be appropriately selected according to the type of gel-forming substance. For example, when the gel-forming substance is sodium alginate, a calcium chloride aqueous solution may be used as the gelation solution. The concentration of the calcium chloride aqueous solution is not particularly limited as long as it can induce the gelation of the sodium alginate aqueous solution, but may be, for example, 1 to 20 wt%, preferably 5 to 15 wt%, and more preferably 8 to 12 wt%. In addition, when the gel-forming substance is a polysaccharide such as agarose, gelatin, collagen, or the like, the gelation-inducing liquid can be, for example, cold water. The temperature of the cold water may be any temperature at which the gelation of the gel-forming substance is induced, and can be appropriately selected depending on the type of the gel-forming substance. Examples of the temperature of the cold water include 0 to 50°C or less, 0 to 40°C, 0 to 30°C, or 0 to 20°C. In addition, when the polysaccharide gels in the presence of a metal salt (such as an alkali metal salt or an alkaline earth metal salt), the gelation-inducing liquid can be an aqueous solution containing the metal salt. When the gel-forming substance is a polyamino acid or a synthetic polymer, the gelation-inducing liquid may be, for example, a solution containing a condensing agent or a crosslinking agent. Furthermore, when the gel-forming substance is a stimulus-responsive sol-gel transition polymer, examples of the gelation-inducing liquid include a solution having a stimulus (temperature, pH, solute concentration, etc.) that induces the sol-gel transition of the gel-forming substance. The gelation-inducing liquid is preferably one that does not adversely affect the survival of the cellulose-producing bacteria.
[0020] A suspension containing a gel-forming substance and target particles 22 (hereinafter also referred to as a "target particle suspension") can be prepared, for example, by preparing an aqueous solution of a gel-forming substance (gel-forming substance aqueous solution) and suspending target particles 22 in the aqueous solution. The concentration of the gel-forming substance in the gel-forming substance aqueous solution is not particularly limited as long as it is a concentration at which a particulate gel can be formed when the gel-forming substance aqueous solution is dropped into a gelation-inducing liquid. In general, the higher the concentration of the gel-forming substance, the higher the viscosity of the gel-forming substance aqueous solution. Therefore, a concentration at which the target particles 22 can be uniformly dispersed and fluidity to the extent that it can be sucked up with a pipette or the like is maintained is preferable. In addition, generally, the lower the concentration of the gel-forming substance, the lower the stability of the particulate gel 20, and there is a possibility that it will swell in the step B described below. Therefore, a concentration at which the particulate gel 20 does not swell excessively in the step B or the like is preferable. For example, when the gel-forming substance is sodium alginate, the concentration of the sodium alginate aqueous solution may be 0.1 to 10 wt%. The concentration of the sodium alginate aqueous solution is preferably 0.3 to 5 wt%, more preferably 0.5 to 3 wt%, even more preferably 0.8 to 2 wt%, and particularly preferably 1 wt%. For example, when the gel-forming substance is agarose (agar), the concentration of the agarose aqueous solution may be 0.1 to 10 wt%. The concentration of the sodium alginate aqueous solution is preferably 0.3 to 5 wt%, more preferably 0.5 to 4 wt%, even more preferably 0.8 to 3 wt%, and particularly preferably 2 wt%.
[0021] The amount of target particles 22 suspended in the gelling substance aqueous solution is not particularly limited and can be any amount. By controlling the content of target particles 22 in the target particle suspension, the amount of target particles 22 encapsulated in the bacterial cellulose membrane capsules can be controlled. The content of target particles 22 in the target particle suspension is preferably an amount that does not hinder the gelling of the target particle suspension. The content of target particles 22 in the target particle suspension can be, for example, 0.1 to 50 wt%, preferably 0.5 to 30 wt%, and more preferably 1 to 10 wt%.
[0022] The size of the particulate gel 20 can be controlled by the droplet size of the target particle suspension dropped into the gelation-inducing liquid. The droplet size is not particularly limited as long as it is a size that allows the formation of a particulate gel. In the manufacturing method of this embodiment, the size of the bacterial cellulose membrane capsule is approximately the same as the size of the particulate gel 20. Therefore, the size of the particulate gel 20 can be adjusted according to the target size of the bacterial cellulose membrane capsule. Furthermore, in the manufacturing method of this embodiment, since the particulate gels 20 need to be handled one by one in step B described below, it is preferable that the size be such that they can be handled one by one. The diameter d of the particulate gel 20 is, for example, 1 to 5 mm, preferably 1.5 to 4 mm, more preferably 2 to 3 mm, even more preferably 2.2 to 2.8 mm, and particularly preferably about 2.5 mm. The amount of droplets used to prepare the particulate gel 20 is, for example, 10 to 100 μL, preferably 20 to 80 μL, more preferably 30 to 70 μL, even more preferably 40 to 60 μL, and particularly preferably 50 μL.
[0023] By step A, a particulate gel 20 composed of a gel 21 and target particles 22 present inside the gel 21 can be obtained.
[0024] (Process B) In step B, droplets of culture liquid of cellulose-producing bacteria containing particulate gel are prepared.
[0025] <Cellulose-producing bacteria> The cellulose-producing bacteria are not particularly limited, and any bacteria that produce cellulose can be used. Examples of cellulose-producing bacteria include the genus Acetobacter, Agrobacterium, Rhizobium, Sarcina, Pseudomonas, Achromobacter, Alcaligenes, Aerobacter, Azotobacter, and Gluconacetobacter. Among them, acetic acid bacteria such as Acetobacter and Gluconacetobacter are preferred from the viewpoint of availability and ease of handling, and Acetobacter xylinum, Acetobacter pasteurianus, and Gluconacetobacter xylinus are more preferred.
[0026] <Liquid medium> The liquid medium used for culturing the cellulose-producing bacteria can be any liquid medium used for culturing aerobic bacteria, without any particular limitations. The liquid medium must contain appropriate nutrients necessary for the growth of the cellulose-producing bacteria. In addition, the liquid medium must have an osmotic pressure and / or hydrogen ion concentration that allows the growth of the cellulose-producing bacteria. The liquid medium preferably contains appropriate amounts of a carbon source and a nitrogen source. Examples of carbon sources include glucose (grape sugar), sucrose (cane sugar), maltose, fructose, mannose, mannitol, sorbitol, erythritol, invert sugar, cellobiose, pulp sludge hydrolysate, various molasses (blackstrap molasses), and glycerin. Among them, the carbon source is preferably glucose. One carbon source may be used alone, or two or more carbon sources may be used in combination. For example, a mixture of glucose and other sugars such as fructose, sugar, mannose, etc. may be used. Examples of carbon sources that may be used include starch hydrolysate, citrus molasses, beet molasses, beet juice, sugarcane juice, and fruit juice. Examples of the nitrogen source include various amino acids, peptone, yeast extract, meat extract, corn steep liquor, ammonium salts, nitrates, etc. The nitrogen source may be used alone or in combination of two or more kinds.
[0027] In addition to a carbon source and a nitrogen source, the liquid medium may contain components commonly used in bacterial culture media, such as metal ion sources such as Na, K, Ca, Fe, Zn, Mn, Cu, and Mg, various vitamins, pH adjusters, and antifoaming agents.
[0028] Examples of compounds containing metal ions include FeSO 4 , CaCl 2 , Na 2 MoO 4 , ZnSO 4 , MnSO 4 , CuSO 4 , and MgSO 4 and the like, as well as hydrated salts thereof.
[0029] Examples of vitamins include inositol, nicotinic acid, pyridoxylated hydrochloride, thiamine hydrochloride, calcium pantothenate, riboflavin, p-aminobenzoic acid, folic acid, and biotin.
[0030] Ethanol may be added to the liquid medium. It is known that the addition of ethanol increases the amount of bacterial cellulose produced. The amount of ethanol to be added is, for example, 1.0 g / L to 6.0 g / L.
[0031] The pH of the liquid medium is not particularly limited as long as the cellulose-producing bacteria can grow and produce bacterial cellulose, but generally, the pH range is 3 to 7. The pH is preferably 4 to 6, and can be set to, for example, about 5. The pH of the liquid medium can be adjusted using any pH adjuster. Examples of the pH adjuster include alkali salts such as sodium hydroxide, potassium hydroxide, and sodium carbonate; organic acids such as acetic acid and citric acid; and inorganic acids such as hydrochloric acid, sulfuric acid, and nitric acid.
[0032] A specific example of a liquid medium is Hestrine-Schramm's medium (HS medium) (Hestrin, S. et al., Biochem. J., 1954, 58, 345-352.).
[0033] The liquid medium may have a high glucose content in order to increase the rate of bacterial cellulose production by the cellulose-producing bacteria. For example, a normal bacterial culture medium to which glucose has been added may be used. The glucose concentration of the liquid medium may be, for example, 3 to 15 w / v%, preferably 5 to 12 w / v%, more preferably 7 to 10 w / v%, and even more preferably about 9 w / v%.
[0034] <Cullosyl production fungal culture fluid> The method for culturing the cellulose-producing bacteria is not particularly limited, and the culture conditions generally used for culturing aerobic bacteria can be used. The culture temperature is generally in the range of 10 to 50°C, preferably 10 to 40°C, more preferably 20 to 40°C, and even more preferably 25 to 35°C.
[0035] As the culture method, any microbial culture method can be used, such as stationary culture, shaking culture, or aeration and agitation culture. As the culture operation method, batch fermentation, fed-batch fermentation, repeated batch fermentation, continuous fermentation, etc. can be used. As the agitation means, for example, an impeller (agitation blade), an airlift fermenter, pump-driven circulation of fermentation broth, etc. can be used alone or in combination.
[0036] The culture apparatus may be any apparatus commonly used for culturing bacteria without any particular limitations. For example, a jar fermenter equipped with an agitator capable of keeping the inside of the tank at a constant temperature may be used.
[0037] The culture liquid used to prepare the culture droplets can be, for example, a liquid medium inoculated with cellulose-producing bacteria and cultured for about 1 to 10 days, preferably about 2 to 5 days, and more preferably about 3 to 4 days.
[0038] ≪Culture droplet≫ A culture droplet of a cellulose-producing bacterium containing particulate gel 20 can be prepared, for example, by immersing the particulate gel 20 in a culture solution 30 of a cellulose-producing bacterium, then removing the particulate gel 20 from the culture solution 30 and dropping it onto a hydrophobic medium 50. By immersing the particulate gel 20 in the culture solution 30, a layer of the culture solution 30 is formed on the entire surface of the particulate gel 20. The particulate gels 20 with the layer of the culture solution 30 formed on their surfaces are taken out one by one and dropped into a hydrophobic medium 50, thereby producing a culture droplet D1 containing one particulate gel 20. The culture droplet D1 is composed of the particulate gel 20 and the layer of the culture solution 30 formed on the surface of the particulate gel 20.
[0039] <Hydrophobic medium> The hydrophobic medium 50 is not particularly limited, and a known medium can be used. The specific gravity of the hydrophobic medium 50 is preferably approximately equal to or smaller than the specific gravity of the culture solution. The specific gravity of the hydrophobic medium 50 can be, for example, 0.8 to 1.1 times the specific gravity of the culture solution, preferably 0.9 to 1.05 times the specific gravity of the culture solution, and more preferably 0.95 to 1.0 times. By setting the specific gravity of the hydrophobic medium 50 within the above range, the culture droplet D1 can be suspended or precipitated in the hydrophobic medium, and a spherical bacterial cellulose membrane 31 can be formed at the interface between the hydrophobic medium 50 and the culture droplet D1. In addition, the hydrophobic medium 50 preferably has oxygen permeability so that oxygen is supplied to the cellulose-producing bacteria in the culture droplet D1. Examples of such hydrophobic media 50 include fatty acids such as saturated fatty acids or unsaturated fatty acids, aliphatic hydrocarbons, cyclic hydrocarbons, aromatic hydrocarbons, heterocyclic compounds, and silicone oils.
[0040] Examples of saturated fatty acids include linear or branched saturated fatty acids having 4 to 30 carbon atoms, such as butanoic acid, pentanoic acid, hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, decanoic acid, dodecanoic acid, tetradecanoic acid, pentadecanoic acid, heptadecanoic acid, and toctadecanoic acid. Examples of unsaturated fatty acids include linear or branched unsaturated fatty acids having 4 to 30 carbon atoms, such as hexadecanoic acid, octadecanoic acid, and icosanoic acid. Examples of aliphatic hydrocarbons include aliphatic hydrocarbons having 4 to 30 carbon atoms, such as hexane, heptane, and decane. Examples of cyclic hydrocarbons include cyclic hydrocarbons having 6 to 30 carbon atoms, such as cyclohexane and cycloheptane. Examples of aromatic hydrocarbons include benzene, toluene, xylene, and naphthalene. Examples of heterocyclic compounds include imidazole and pyridine. Examples of silicone oils include dimethyl silicone oil, cyclic silicone oil, methylphenyl silicone oil, methylhydrogen silicone oil, higher fatty acid ester modified silicone oil, alkyl / aralkyl modified silicone oil, alkyl modified silicone oil, amino modified silicone oil, epoxy modified silicone oil, alkyl / polyether modified silicone oil, polyether modified silicone oil, carbinol modified silicone oil, and the like. The hydrophobic medium may be used alone or in combination of two or more kinds. Among these, from the viewpoint of oxygen permeability, it is preferable to use silicone oil, and it is more preferable to use silicone oil alone.
[0041] The hydrophobic medium 50 is placed in an appropriate container having a size capable of accommodating the particulate gel 20. In the example of FIG. 1, the hydrophobic medium 50 is placed in a round-bottomed (U-bottomed) well 41 of a 96-well microplate 40. The container for accommodating the hydrophobic medium 50 is not particularly limited, but a round-bottomed container having a radius of curvature slightly larger than that of the particulate gel 20 is preferable. By using such a container, the shape of the culture droplet D1 is stably maintained, and a spherical bacterial cellulose film 31 having a good shape can be formed. The radius of curvature of the bottom of the container can be, for example, 1.1 to 3 times the radius of the particulate gel 20, and is preferably about 1.1 to 2 times. The material of the container is not particularly limited, but is preferably oxygen permeable. When the container has oxygen permeability, a bacterial cellulose film can be formed well even at the interface between the container and the particulate gel 20. Examples of such materials include polyolefin resins such as polypropylene. Alternatively, the inner surface of the container may be hydrophobically coated. When the inner surface of the container is hydrophobically coated, the hydrophobic medium 50 can easily enter between the container and the particulate gel 20, and oxygen can be supplied by the hydrophobic medium 50.
[0042] It is preferable that one culture droplet D1 is accommodated in each compartment (well 41 in FIG. 1) of the container. By accommodating one culture droplet D1 in each compartment, contact between the culture droplets D1 can be prevented, and a spherical bacterial cellulose film 31 with a good shape can be formed.
[0043] (Process C) In step C, the culture droplets are cultured in a hydrophobic medium to form a bacterial cellulose film at the interface between the culture droplets and the hydrophobic medium, thereby obtaining a spherical bacterial cellulose film encapsulating the particulate gel.
[0044] The culture conditions for the culture droplet D1 in the hydrophobic medium 50 are not particularly limited, and conditions typically used for culturing aerobic bacteria can be used. The culture temperature can be the same as that mentioned in step B above. The culture may be performed by static culture or may be performed with slow stirring. In addition, during the culture period, the culture droplet D1 may be rotated to change the part of the culture droplet D1 that contacts the inner surface of the container. The formation of the bacterial cellulose film tends to be delayed in the part of the culture droplet D1 that contacts the container compared to the part that contacts the hydrophobic medium 50. Therefore, by appropriately changing the contact part with the container during the culture period, it is possible to form a spherical bacterial cellulose film 31 having a more uniform thickness. The culture droplet D1 may be rotated once or multiple times during the culture period. The timing of the rotation of the culture droplet D1 is not particularly limited, but may be, for example, 2 to 4 days, preferably 3 days, after the start of the culture.
[0045] The culture in step C is carried out until a spherical bacterial cellulose film 31 is formed covering the entire surface of the particulate gel 20 and the spherical bacterial cellulose film 31 has an appropriate thickness. When an HS medium is used, for example, the culture is preferably carried out for 6 days or more, more preferably 7 days or more, even more preferably 10 days or more, and particularly preferably 14 days or more. The upper limit of the culture period is not particularly limited, but can be, for example, 25 days or less, 20 days or less, or 15 days or less, etc. Alternatively, when a medium with a high glucose content (e.g., HS medium containing 9 w / v % glucose) is used, the rate of bacterial cellulose film formation is faster, and the culture period can be shortened. In this case, the culture period is preferably, for example, 5 days or more, more preferably 6 days or more, and even more preferably 7 days or more. The upper limit of the culture period is not particularly limited, and can be, for example, 20 days or less, 15 days or less, or 10 days or less, etc.
[0046] By the step C, it is possible to obtain a spherical bacterial cellulose film 31 encapsulating the particulate gel 20. The spherical bacterial cellulose film 31 is formed as a layer of the bacterial cellulose film covering the entire surface of the particulate gel 20.
[0047] (Process D) In step D, the particulate gel encapsulated in the spherical bacterial cellulose membrane is dissolved.
[0048] The method for dissolving the particulate gel 20 can be appropriately selected depending on the type of gel-forming substance used to form the particulate gel 20. For example, in the case of a gel-forming substance that gels in the presence of a metal salt, the particulate gel 20 can be dissolved by immersing in an appropriate buffer solution such as phosphate buffered saline (PBS). For example, in the case of a gel-forming substance that is sodium alginate, a buffer solution such as PBS can be used to dissolve the particulate gel 20. The spherical bacterial cellulose membrane 31 encapsulating the particulate gel 20 may be immersed in PBS and left to stand until the particulate gel 20 is completely dissolved. Alternatively, when the gel-forming substance is a substance that gels at low temperatures, such as agarose, the particulate gel 20 can be dissolved by increasing the temperature. For example, the spherical bacterial cellulose membrane 31 encapsulating the particulate gel 20 may be immersed in pure water or a buffer solution such as PBS, and the temperature may be increased to a temperature above the gel re-dissolving temperature and allowed to stand until all of the particulate gel 20 is dissolved. Alternatively, a buffer solution that has been heated to a temperature above the gel re-dissolving temperature in advance may be used. The temperature may be, for example, 70° C. or higher, preferably 80° C. or higher, more preferably 90° C. or higher, and even more preferably 95° C. or higher.
[0049] In step D, the particulate gel 20 is dissolved to obtain bacterial cellulose membrane capsules C1 encapsulating the target particles 22. The bacterial cellulose membrane capsules C1 obtained in step D can be stored by immersing them in a suitable liquid 61 capable of retaining the bacterial cellulose membrane capsules C1. Since the liquid 61 passes through the three-dimensional mesh structure of the spherical bacterial cellulose membranes 31, the inside of the bacterial cellulose membrane capsules C1 is also filled with the liquid 61. It is preferable that the liquid 61 does not adversely affect the target particles 22 and the spherical bacterial cellulose membranes 31. Examples of the liquid 61 include, but are not limited to, a buffer solution such as PBS; water:alcohol such as ethanol. The bacterial cellulose membrane capsules C1 may be washed with a large amount of liquid 61 before being stored in liquid 61.
[0050] (Other processes) The production method of this embodiment may include other steps in addition to the above steps A to D. Examples of the other steps include a step of removing the hydrophobic medium from the spherical bacterial cellulose membrane (step E) and a step of removing the cellulose-producing bacteria (step F).
[0051] ≪Process E≫ In addition to the above steps A to D, the manufacturing method of this embodiment preferably includes a step E of removing the hydrophobic medium from the spherical bacterial cellulose membrane. The hydrophobic medium 50 can be removed by immersing the bacterial cellulose membrane capsule C1 in a solvent 60 compatible with the hydrophobic medium 50. By immersing in the solvent 60, the hydrophobic medium 50 remaining in the bacterial cellulose membrane capsule C1 is transferred into the solvent. This allows the hydrophobic medium 50 to be removed from the bacterial cellulose membrane capsule C1. The solvent 60 is not particularly limited as long as it is compatible with the hydrophobic medium 50. Examples of the solvent 60 include organic solvents, and can be appropriately selected depending on the type of the hydrophobic medium 50. For example, when the hydrophobic medium 50 is silicone oil, specific examples of the solvent 60 include, but are not limited to, ethanol, chloroform, tetrahydrofuran, hexane, etc. It is more preferable that the solvent 60 does not adversely affect the target particles 22. When the bacterial cellulose membrane capsule C1 is used for medical, edible, cosmetic, or other purposes and the hydrophobic medium 50 is compatible with ethanol, it is preferable to use ethanol because of its high safety.
[0052] In the case where the particulate gel 20 is dissolved using a buffer solution such as PBS in step D, the hydrophobic medium 50 is liberated from the bacterial cellulose membrane capsules C1 into the buffer solution. Therefore, most of the hydrophobic medium 50 can be removed in step D. In this case, step E can be omitted.
[0053] When step E is performed, it is preferable to perform it after the step D. By performing step E after step D, it is possible to prevent the particulate gel 20 from being hardened by the solvent 60 used in step E.
[0054] ≪Process F≫ The manufacturing method of this embodiment preferably includes, in addition to the above steps A to D, a step F of removing cellulose-producing bacteria. The cellulose-producing bacteria can be removed by, for example, immersing the bacterial cellulose membrane capsule C1 in an alkali such as sodium hydroxide; an acid such as hydrochloric acid or sulfuric acid; a bleaching agent such as sodium hypochlorite or hydrogen peroxide; a bacterial cell-dissolving enzyme such as lysozyme; or a surfactant such as sodium lauryl sulfate or deoxycholic acid. Alternatively, the cellulose-producing bacteria may be sterilized by heating, and the bacterial residue may be washed with pure water or the like. These treatments may also be combined. Among these, since an alkali-soluble residue can be efficiently removed, it is preferable to use an alkali such as sodium hydroxide in step F. When step F is performed, it may be performed before or after step D, but it is preferable to perform it after step D.
[0055] In addition to the above steps, the manufacturing method of this embodiment may include a step of immersing the bacterial cellulose membrane capsules C1 in water to wash them. The bacterial cellulose membrane capsules C1 may also be dried and aerogelled using a supercritical fluid such as supercritical carbon dioxide. For example, the bacterial cellulose membrane capsules C1 may be immersed in a non-aqueous medium such as ethanol, and then aerogelled by passing supercritical carbon dioxide through the non-aqueous medium at a flow rate of, for example, 2.0 mL / min under conditions of, for example, 60° C. and 20 MPa.
[0056] According to the manufacturing method of this embodiment, it is possible to obtain bacterial cellulose membrane capsules encapsulating large particles that cannot pass through the three-dimensional mesh structure of the bacterial cellulose membrane. Since the particles encapsulated in the capsules cannot pass through the bacterial cellulose membrane, they do not leak out of the capsules. In addition, the size of the bacterial cellulose membrane capsules obtained by the production method of this embodiment can be controlled by adjusting the size of the particulate gel, so that bacterial cellulose membrane capsules of any size, for example, in the range of 1 to 5 mm in diameter can be obtained. Furthermore, since any particle of 1 μm or more can be encapsulated in the bacterial cellulose membrane capsules, they can be used for various applications such as medical products, foods, cosmetics, and industrial materials by selecting the particle.
[0057] <Second embodiment> 2 is a diagram illustrating one embodiment of a method for producing bacterial cellulose membrane capsules. In the production method of this embodiment, in step B, a culture droplet D2 containing a plurality of particulate gels 20 is produced. Moreover, the size of the particulate gels 20 produced in step A is usually smaller than that of the particulate gels 20 produced in the first embodiment. The other steps can be performed in the same manner as in the first embodiment.
[0058] In the manufacturing method of this embodiment, since a plurality of particulate gels 20 are contained in the culture droplet D2, the amount of target particles 22 to be encapsulated in the bacterial cellulose membrane capsule C2 can be controlled by the number of particulate gels 20 contained in the culture droplet D2. Therefore, this method is suitable for encapsulating a desired amount of target particles 22 with small particle diameters in the bacterial cellulose membrane capsule C2.
[0059] (Process A) The size of the particulate gel 20 prepared in step A is not particularly limited as long as a culture droplet containing a plurality of particulate gels 20 can be formed in step B. The diameter d of the particulate gel 20 is, for example, 0.1 to 3 mm, preferably 0.3 to 2 mm, more preferably 0.5 to 1.5 mm, even more preferably 0.7 to 1.2 mm, and particularly preferably about 1.0 mm. The amount of droplets used to prepare the particulate gel 20 is, for example, 0.05 to 30 μL, preferably 0.1 to 20 μL, more preferably 0.5 to 10 μL, even more preferably 1 to 5 μL, and particularly preferably 1.5 μL.
[0060] The target particles 22 are not particularly limited as long as they have a particle size of 1 μm or more. The particle size of the particulate gel 20 can be appropriately selected according to the size of the particulate gel 20. The target particles 22 are usually smaller than those used in the first embodiment. From the viewpoint of ease of forming the particulate gel 20, the particle size of the target particles 22 can be, for example, 300 μm or less. The particle size of the target particles 22 is preferably 200 μm or less, more preferably 100 μm or less, even more preferably 50 μm or less, and particularly preferably 10 μm or less.
[0061] The concentration of the gel-forming substance in the target particle suspension is usually lower than that in the first embodiment, from the viewpoint of ensuring fluidity that allows collection of a small amount. For example, when the gel-forming substance is sodium alginate, the concentration of the sodium alginate aqueous solution is 0.05 to 5 wt%. The concentration of the sodium alginate aqueous solution is preferably 0.1 to 3 wt%, more preferably 0.3 to 1 wt%, further preferably 0.4 to 0.8 wt%, and particularly preferably 0.5 wt%.
[0062] (Process B) In step B, a culture droplet D2 is prepared that includes a plurality of particulate gels 20. The number of particulate gels 20 contained in the culture droplet D2 is not particularly limited, and may be, for example, 2 to 100, 2 to 80, 2 to 50, 2 to 30, 2 to 20, or 2 to 10, etc.
[0063] The culture droplet D2 containing a plurality of particulate gels 20 can be prepared, for example, by immersing the particulate gel 20 in a culture solution 30 of a cellulose-producing bacterium, and then collecting a certain amount of the culture solution 30 containing a plurality of particulate gels 20 and dropping it onto a hydrophobic medium 50. The amount of the culture solution 30 dropped onto the hydrophobic medium 50 is not particularly limited as long as the culture droplet D2 can be formed in the hydrophobic medium 50. Examples of the amount of the culture solution 30 dropped onto the hydrophobic medium 50 include 0.5 to 300 μL, 1 to 200 μL, 3 to 100 μL, 5 to 50 μL, 7 to 30 μL, or 8 to 20 μL. The volume of the culture solution 30 is a volume containing a plurality of particulate gels 20. A specific example is 10 μL. In the manufacturing method of this embodiment, the size of the bacterial cellulose membrane capsule C2 can be controlled by the amount of the culture solution 30 dropped onto the hydrophobic medium 50. For example, when 10 μL of the culture solution 30 is used, bacterial cellulose membrane capsules C2 having a diameter of about 2.8 to 3 mm can be formed.
[0064] As in the first embodiment, the hydrophobic medium 50 is placed in an appropriate container of a size capable of accommodating the amount of the culture solution 30 to be dropped. For example, a container with a capacity per compartment of 5 times or more, preferably 10 times or more, the volume of the culture solution 30 to be dropped can be used. As in the first embodiment, a specific example of the container is the round-bottom (U-bottom) well 41 of a 96-well microplate 40.
[0065] It is preferable that one culture droplet D2 is accommodated in each compartment (well 41 in FIG. 2) of the container. By accommodating one culture droplet D2 in each compartment, contact between the culture droplets D1 can be prevented, and a spherical bacterial cellulose film 31 with a good shape can be formed.
[0066] (Process C, Process D) Steps C and D can be performed in the same manner as in the first embodiment.
[0067] (Other processes) The manufacturing method of this embodiment may include other steps in addition to steps A to D, as in the first embodiment. Examples of the other steps include the same steps as those listed in the first embodiment.
[0068] The size of the bacterial cellulose membrane capsules obtained by the production method of this embodiment can be controlled by adjusting the amount of culture solution dropped into the hydrophobic medium, so that bacterial cellulose membrane capsules of any size, for example, in the range of 1 to 5 mm in diameter can be obtained. Furthermore, since any particle of 1 μm or more can be encapsulated in the bacterial cellulose membrane capsules, they can be used for various applications such as medical products, foods, cosmetics, and industrial materials by selecting the particle.
[0069] [Bacterial cellulose membrane capsule] In one embodiment, a bacterial cellulose membrane capsule is provided. The bacterial cellulose membrane capsule of this embodiment includes a spherical bacterial cellulose membrane and particles having a particle diameter of 1 μm or more. The particles are present in an internal space partitioned by the spherical bacterial cellulose membrane.
[0070] The bacterial cellulose membrane capsule of this embodiment can be produced by the bacterial cellulose membrane capsule production method described above. Examples of the bacterial cellulose membrane capsule include bacterial cellulose membrane capsule C1 obtained by the first embodiment of the production method, and bacterial cellulose membrane capsule C2 obtained by the second embodiment.
[0071] The spherical bacterial cellulose membrane need only have a roughly spherical appearance, and does not need to be completely spherical. The spherical bacterial cellulose membrane separates the internal space inside the bacterial cellulose membrane from the external space outside the bacterial cellulose membrane. The spherical bacterial cellulose membrane has a three-dimensional mesh structure formed by the bacterial cellulose membrane. The spherical bacterial cellulose membrane preferably does not have pores with a diameter of 1 μm or more, and more preferably does not have pores other than those formed by the three-dimensional mesh structure.
[0072] Particles having a particle diameter of 1 μm or more are present in the internal space of the spherical bacterial cellulose membrane, which is partitioned by the spherical bacterial cellulose membrane. The particles may be present in the internal space in a free state or may be attached to the inner surface of the bacterial cellulose membrane.
[0073] The bacterial cellulose membrane capsule may contain other components in addition to the above components. Examples of other components include liquid components. The bacterial cellulose membrane capsule is usually stored in a liquid. In this case, the three-dimensional mesh structure of the bacterial cellulose membrane and the internal space of the bacterial cellulose membrane are filled with the liquid. Examples of the liquid include water, buffer solutions such as PBS, and alcohols such as ethanol.
[0074] The bacterial cellulose membrane capsule may be freeze-dried or dried using a supercritical fluid such as supercritical carbon dioxide, and then aerogelled.
[0075] The bacterial cellulose membrane capsule of this embodiment can encapsulate any particle having a particle size of 1 μm or more, and can therefore be used for various applications such as medical products, foods, cosmetics, and industrial materials depending on the selection of particles.
[0076] [Pharmaceutical composition] In one embodiment, the present invention provides a pharmaceutical composition comprising the bacterial cellulose membrane capsule of the above embodiment.
[0077] The bacterial cellulose membrane capsule of the above embodiment can encapsulate any particle having a particle diameter of 1 μm or more. When the particle having a particle diameter of 1 μm or more is a drug having pharmacological activity, the composition containing the bacterial cellulose membrane capsule encapsulating the drug can be used as a pharmaceutical composition.
[0078] The drug to be encapsulated in the bacterial cellulose membrane capsule is not particularly limited as long as it is a particle having a particle size of 1 μm or more. In addition, even if the drug itself has a particle size of less than 1 μm, the drug may be fixed to a carrier particle having a particle size of 1 μm or more and encapsulated in the bacterial cellulose membrane capsule. Examples of the material of the carrier particle include, but are not limited to, porous silica, hydroxyapatite, metal, resin, etc. Examples of the drug include, but are not limited to, vitamins and their derivatives, anti-inflammatory agents, anti-inflammatory agents, blood circulation promoters, stimulants, hormones, irritation relief agents, analgesics, cell activators, plant / animal / microorganism extracts, antipruritic agents, anti-inflammatory analgesics, antifungal agents, antihistamines, hypnotics, sedatives, tranquilizers, antihypertensive agents, antihypertensive diuretics, antibiotics, anesthetics, antibacterial substances, antiepileptic agents, coronary vasodilators, herbal medicines, antipruritics, keratin softening and peeling agents, etc. One type of drug may be used alone, or two or more types may be used in combination.
[0079] Particles with a particle size of 1 μm or more include, for example, adsorbents that adsorb disease-causing substances. If the disease-causing substances are molecules with a size of less than 1 μm, the disease-causing substances permeate the bacterial cellulose membrane and are adsorbed by the adsorbent. On the other hand, adsorbents with a particle size of 1 μm or more are not released outside the bacterial cellulose membrane capsule. Therefore, the disease-causing substances adsorbed to the adsorbent can be enclosed within the bacterial cellulose membrane capsule.
[0080] For example, activated carbon is used as a drug that adsorbs uremia causative substances (e.g., indole). Therefore, bacterial cellulose membrane capsules containing activated carbon can be used as pharmaceutical compositions for treating or preventing uremia. The particle size of the activated carbon contained in the bacterial cellulose membrane capsules may be 1 μm or more. In general, the amount of uremia causative substances adsorbed increases when a larger number of activated carbon particles with a smaller particle size are contained. Therefore, the particle size of the activated carbon particles is preferably, for example, 1 to 1000 μm, more preferably 1 to 800 μm, further preferably 1 to 500 μm, and particularly preferably 1 to 300 μm. More preferably, the particle size of the activated carbon particles is 1 to 100 μm, 1 to 50 μm, 1 to 30 μm, or 1 to 10 μm.
[0081] The amount of the encapsulated activated carbon particles is not particularly limited, but may be, for example, 0.01 to 1.0 mg, preferably 0.03 to 0.6 mg, and more preferably 0.05 to 0.5 mg.
[0082] Furthermore, for example, potassium adsorbents (calcium polystyrene sulfonate, etc.) are used as drugs that adsorb potassium in the intestinal tract. Therefore, bacterial cellulose membrane capsules containing a potassium adsorbent can be used as pharmaceutical compositions for treating or preventing hyperkalemia. The particle size of the potassium adsorbent to be contained in the bacterial cellulose membrane capsule may be 1 μm or more, and examples of the particle size include the same as that of the activated carbon. The amount of potassium adsorbent to be contained is not particularly limited, and examples of the amount include the same as that of the activated carbon.
[0083] Moreover, the particles having a particle size of 1 μm or more may be enzyme immobilized carriers. For example, bacterial cellulose membrane capsules containing enzyme immobilized carriers can be used as pharmaceutical compositions for treating or preventing deficiencies of the enzyme. The particle size of the enzyme immobilized carrier to be encapsulated in the bacterial cellulose membrane capsules may be 1 μm or more, and examples of the particle size include the same as that of the activated carbon. The amount of the enzyme immobilized carrier to be encapsulated is not particularly limited and can be appropriately selected depending on the type of enzyme, and examples of the particle size include the same as that of the activated carbon. Examples of the enzyme to be immobilized include decomposition enzymes of disease-causing substances and synthesis enzymes of deficiency substances. As the carrier to immobilize the enzyme, known ones can be used without any particular limitation, and examples of the carrier include chitosan beads, alginate beads, silica beads, and the like.
[0084] In addition, because immune cells cannot penetrate into bacterial cellulose membranes, conventionally, proteins that can be antigens can be protected from immune cells by encapsulating them in bacterial cellulose membrane capsules. Therefore, by encapsulating proteins in bacterial cellulose membrane capsules, it is expected that the proteins can be retained in the body. For example, by encapsulating a carrier on which an enzyme derived from a different organism that can be an antigen is immobilized in a bacterial cellulose membrane capsule, it is expected that the enzyme can be inhibited from being inactivated by immune cells and its function can be expressed for a long period of time. In addition, by placing in the body of a patient who is congenitally deficient in a specific enzyme, a bacterial cellulose membrane capsule containing an enzyme-immobilized carrier on which the enzyme derived from a human or a similar enzyme derived from a different organism is immobilized, it is expected that the enzyme will function in the body for a long period of time. For example, in the case of acatalaseemia, it is possible to express an action similar to that of catalase by encapsulating a carrier on which an enzyme capable of decomposing hydrogen peroxide (active oxygen), such as superoxide dismutase or glutathione peroxidase, that is immobilized in a bacterial cellulose membrane capsule and placing the carrier in the body.
[0085] The enzyme immobilized on the enzyme-immobilized carrier may be an enzyme that metabolizes a prodrug. A prodrug is a pharmaceutical that is transformed into an active metabolite by the metabolic action of the living body and shows its medicinal effect. By encapsulating a carrier on which an enzyme that metabolizes a prodrug is immobilized in a bacterial cellulose membrane capsule and transplanting the carrier to a target site, the prodrug is metabolized at the site to generate an active metabolite, and the medicinal effect of the active metabolite is locally exerted. For example, encapsulated cells expressing cytochrome P450 enzymes have been transplanted to a tumor site, and the antitumor activity of the prodrug has been confirmed (P Karle et al., Adv. Exp. Med. Biol. 451: 97-106. (1998).), but a cheaper system can be constructed by using a bacterial cellulose membrane capsule encapsulating a carrier on which cytochrome p450 is immobilized.
[0086] The enzyme immobilized on the enzyme immobilization carrier may be a plurality of enzymes that catalyze a multi-step reaction process. For example, avidin and biotin show high affinity and specificity, and form a non-covalent bond with a very large binding constant. In this way, proteins that would react when coexisting can be immobilized on separate carriers and encapsulated in the same or separate bacterial cellulose membrane capsules, allowing them to coexist. This allows the multi-step reaction process to be expressed in vivo and in vitro.
[0087] The size of the bacterial cellulose membrane capsule is not particularly limited, but may be, for example, 0.1 to 3 mm, preferably 0.3 to 2 mm, more preferably 0.5 to 1.5 mm, even more preferably 0.7 to 1.2 mm, and particularly preferably about 1.0 mm.
[0088] The pharmaceutical composition of the present embodiment may contain any component in addition to the bacterial cellulose membrane capsule. The optional component may be, for example, a pharma- ceutically acceptable carrier. The term "pharma-ceutically acceptable carrier" refers to a carrier that does not inhibit the physiological activity of the active ingredient and does not show substantial toxicity to the subject of administration. The term "not substantially toxic" refers to the component not showing toxicity to the subject of administration at a dose normally used. In the pharmaceutical composition of the present embodiment, the pharma-ceutically acceptable carrier is a carrier that does not inhibit the pharmacological activity of the drug encapsulated in the bacterial cellulose membrane capsule and does not show substantial toxicity to the subject of administration. The pharma-ceutically acceptable carrier includes any known pharma-ceutically acceptable component that is typically considered to be an inactive component. The pharma- ceutically acceptable carrier is not particularly limited, and examples thereof include solvents, diluents, vehicles, excipients, flow enhancers, binders, granulating agents, dispersing agents, suspending agents, wetting agents, lubricants, disintegrants, solubilizing agents, stabilizers, emulsifying agents, fillers, preservatives (e.g., antioxidants), chelating agents, flavoring agents, sweetening agents, thickening agents, buffers, coloring agents, etc. One type of pharma- ceutically acceptable carrier may be used alone, or two or more types may be used in combination.
[0089] The pharmaceutical composition of the present embodiment may contain other components in addition to the bacterial cellulose membrane capsule and the pharma- ceutically acceptable carrier. The other components are not particularly limited, and any components commonly used in the pharmaceutical field can be used without particular limitation.
[0090] The dosage form of the pharmaceutical composition of this embodiment is not particularly limited, and may be a dosage form generally used as a pharmaceutical preparation. The pharmaceutical composition of this embodiment may be an oral preparation or a parenteral preparation. Examples of oral preparations include tablets, coated tablets, pills, powders, granules, capsules, syrups, fine granules, liquids, drops, and emulsions. Examples of parenteral preparations include suppositories, ointments, sprays, external preparations, ear drops, eye drops, nasal drops, and inhalants. Pharmaceutical compositions of these dosage forms can be formulated according to standard methods (for example, methods described in the Japanese Pharmacopoeia).
[0091] The administration route of the pharmaceutical composition of this embodiment is not particularly limited, and can be administered orally or parenterally. The parenteral route includes all administration routes other than oral, such as intravenous, intramuscular, subcutaneous, intranasal, intradermal, ophthalmic, intracerebral, rectal, intravaginal, and intraperitoneal administration. The administration may be local or systemic. The administration route of the pharmaceutical composition of this embodiment is preferably oral.
[0092] The pharmaceutical composition of this embodiment can be administered in a therapeutically effective amount of a drug encapsulated in a bacterial cellulose membrane capsule. The term "therapeutically effective amount" refers to an amount of a drug effective for treating or preventing a target disease. The therapeutically effective amount may be appropriately determined depending on the type of drug, the symptoms, weight, age, and sex of the patient, the dosage form of the pharmaceutical composition, and the administration method. For example, the pharmaceutical composition of this embodiment can be administered in a single dose of 0.01 to 1000 mg per kg of the body weight of the subject. The dosage may be 0.15 to 800 mg / kg, 0.5 to 500 mg / kg, 1 to 400 mg / kg, or 1 to 300 mg / kg.
[0093] The administration interval of the pharmaceutical composition of this embodiment may be appropriately determined depending on the symptoms, body weight, age, sex, etc. of the patient, as well as the dosage form of the pharmaceutical composition, the administration method, etc. The administration interval may be, for example, every few hours, once a day, once every 2 to 3 days, once a week, etc. EXAMPLES
[0094] The present invention will be described below with reference to experimental examples, but the present invention is not limited to the following experimental examples.
[0095] Materials and Methods <Materials, etc.> Hestrine-Schramm medium (HS medium) (Hestrin, S. et al., Biochem. J., 1954, 58, 345-352.) was used for culturing cellulose-producing bacteria. Standard HS medium contains 3.0 g of D-glucose (Kanto Chemical Co., Ltd.), 0.5 g of mannitol (Kanto Chemical Co., Ltd.), 0.5 g of peptone (HIPOLYPEPTONE TM , Nippon Pharmaceutical Co., Ltd.), 0.5 g of Bacto TM Yeast extract (BD Biosciences), and 0.1 g of magnesium sulfate heptahydrate (MgSO 4 7H 2 HS medium can be prepared by dissolving 100 mL of HS broth (O; Kanto Chemical Co., Ltd.) in 100 mL of MiliQ water. The density of HS medium at 30 °C was measured using a Baume hydrometer and found to be 1.02 g / cm. 3 It was.
[0096] Silicone oil (KF-56A: 0.995g / cm 3 , 15mm / s 2 , ethanol-soluble oil) were purchased from Shin-Etsu Chemical Co., Ltd. Fluorescent particles (Spectro TM FITC particles, 5.0-5.9 μm, 0.1 w / v% PBS, pH 7.4) were purchased from Spherotech Inc. Other reagents were purchased from Kanto Chemical Co., Ltd.
[0097] The 96-well plate used was a U-bottom type made of polypropylene (290-8353-03R; Caplugs Evergreen).
[0098] <Preparation of bacterial cellulose membrane capsules encapsulating particles> (Method A) Bacterial cellulose membrane capsules encapsulating particles were prepared according to the method shown in FIG.
[0099] <Preparation of gel particles> Alginate gel particles (hereinafter referred to as "Ca-Alg gel") were prepared by dropping 50 μL of 1 wt% sodium alginate aqueous solution (hereinafter referred to as "Na-Alg aqueous solution") containing particles into 10 wt% calcium chloride aqueous solution. An Eppendorf pipette tip (capacity 100 μL) with 1 cm cut from the tip was used to drop the particle-containing 1 wt% Na-Alg aqueous solution. The obtained Ca-Alg gel was immersed in Milli-Q water and washed. The size of the gel particles obtained by this method was about 2.5 mm in diameter.
[0100] <Preparation of particle-encapsulated bacterial cellulose film> The HS medium was sterilized by autoclaving. G. xylinus (IFO13772) was inoculated into the sterilized HS medium and cultured at 30°C for 3 days. The Ca-Alg gel prepared above was then immersed in the culture solution (cell suspension) of G. xylinus and cultured at 30°C for 1 day. Each well of the 96-well plate was then filled with 320 μL of silicone oil, and the Ca-Alg gel with the cell suspension attached to the entire surface was immersed in the silicone oil in each well. One Ca-Alg gel was placed into each well. The 96-well plate was then subjected to static culture at 30°C for 14 days. 14 days after the start of culture, the bacterial cellulose film formed at the interface between the cell suspension and the silicone oil was collected and immersed in phosphate-buffered saline (PBS). This dissolved the Ca-Alg gel. The bacterial cellulose film was then washed with ethanol to remove the silicone oil. The bacterial cellulose film was then immersed in a large amount of distilled water for 1 day. The bacterial cellulose film was then immersed in a 1% (w / v) NaOH aqueous solution at room temperature for 1 day to wash and remove the bacterial cells and alkali-soluble components. The bacterial cellulose film was then washed several times with a large amount of distilled water and stored in the distilled water at room temperature.
[0101] (Method B) Bacterial cellulose membrane capsules encapsulating particles were prepared according to the method shown in FIG.
[0102] <Preparation of gel particles> Gel particles were prepared in the same manner as in Method A, except that 1.5 μL of the 0.5 wt % Na-Alg aqueous solution containing the particles was dropped into a 10 wt % calcium chloride aqueous solution. The size of the gel particles obtained by this method was about 1.0 mm in diameter.
[0103] <Preparation of particle-encapsulated bacterial cellulose film> Bacterial cellulose membranes were prepared as in method A, except that 10 μL of the cell suspension containing one or more Ca-Alg gels was dropped onto the silicone oil in each well.
[0104] <Supercritical CO 2 Preparation of bacterial cellulose membrane aerogel using The hollow spherical bacterial cellulose membrane was immersed in water to swell. The bacterial cellulose membrane was then immersed in a large amount of methanol to wash it, and the swelling solvent was completely replaced from water to methanol. The hollow spherical bacterial cellulose membrane was then immersed in supercritical CO without destroying its microstructure. 2 (scCO 2 ) technique (Buchtova, N. et al., Cellulose, 2016, 23, 2585-2595.). Drying was performed at 40°C, 20 MPa, and CO 2 The drying was carried out under conditions of a flow rate of 2.0 mL / min for 5 hours. 2 The equipment used consisted of a liquid delivery pump (SCF-Get; JASCO), a 50 mL pressure vessel, a gas pressure regulator (SCF-Bpg; JASCO), and a thermostatic water bath (BK33; Yamato Scientific Co., Ltd.).
[0105] <Characteristics of hollow spherical bacterial cellulose membranes> The microstructure of the hollow spherical bacterial cellulose membrane aerogel was observed using a field emission scanning electron microscope (FE-SEM) (S-4500; Hitachi High-Technologies Corporation) at an accelerating voltage of 10 kV. As a pretreatment for FE-SEM observation, Pt-Pd was deposited on the surface of the hollow spherical bacterial cellulose membrane aerogel by ion sputtering (E-1010; Hitachi High-Technologies Corporation).
[0106] [Example 1] <Preparation of bacterial cellulose membrane capsules encapsulating glass beads> Using glass beads (diameter 0.3-0.5 mm) as particles, bacterial cellulose membrane capsules encapsulating glass beads were prepared by method A. Figure 3 shows an optical microscope photograph of bacterial cellulose membrane capsules encapsulating glass beads. As shown in Figure 3, the presence of glass beads was confirmed in the internal space of the bacterial cellulose membrane. Most of the glass beads were able to move within the internal space of the bacterial cellulose membrane, but some of the glass beads were attached to the inner surface of the bacterial cellulose membrane. During the preparation of Ca-Alg gel, glass beads with a high specific gravity may settle in the droplets of Na-Alg aqueous solution, and some of them may be exposed on the Ca-Alg gel surface. It is considered that the glass beads were fixed to the inner surface of the bacterial cellulose membrane due to the interaction (hydrogen bond, entanglement effect, etc.) between the exposed part of the glass beads and the bacterial cellulose fibers. The number of glass beads encapsulated in the bacterial cellulose membrane capsules was the same as the number of beads in the Ca-Alg gel, indicating that the number of particles encapsulated in the bacterial cellulose membrane capsules can be adjusted by adjusting the number of particles encapsulated in the Ca-Alg gel.
[0107] (Study of Na-Alg aqueous solution concentration) In method A, glass bead-encapsulating bacterial cellulose membrane capsules were prepared by changing the concentration of the Na-Alg aqueous solution (0.1-2.0 wt%). The Ca-Alg gel prepared using a high-concentration Na-Alg aqueous solution was highly stable and did not swell even when immersed in water or culture solution. The higher the concentration of the Na-Alg aqueous solution, the higher the viscosity, which tended to make it difficult to aspirate with a micropipette or the like. On the other hand, the Ca-Alg gel prepared using a low-concentration Na-Alg aqueous solution tended to swell when immersed in water or culture solution. The lower the concentration of the Na-Alg aqueous solution, the lower the viscosity, which made it easier to aspirate with a micropipette or the like. Since the size of the bacterial cellulose membrane capsule is controlled by the particle size of the Ca-Alg gel, it is desirable that the particle size of the Ca-Alg gel does not change. From the viewpoint of the stability and ease of aspirating the Ca-Alg gel, it was considered that the concentration of the Na-Alg aqueous solution in method A was preferably 1.0 wt%.
[0108] (Observation of bacterial cellulose membrane) According to method A, Ca-Alg gel containing glass beads was prepared, immersed in cell culture medium, and then cultured in silicone oil for 14 days. The bacterial cellulose membrane obtained after culture was washed with PBS. The bacterial cellulose membrane was then washed with ethanol to remove the silicone oil. This was then dried by supercritical drying. Visual observation of the dried bacterial cellulose membrane confirmed that a gel-like membrane had formed on the entire surface of the spherical bacterial cellulose membrane (Figure 4(A)). Next, we prepared an aerogel of the bacterial cellulose membrane and observed it using FE-SEM. As a result, a network structure of cellulose nanofibers with a diameter of about 30 nm was confirmed (Figure 4(B)). These results indicate that a bacterial cellulose film was formed at the interface between the cell suspension adhering onto the Ca-Alg gel and the silicone oil or 96-well plate.
[0109] (Consideration of cleaning method) According to method A, a bacterial cellulose film was formed in silicone oil. After 14 days of culture in silicone oil, the bacterial cellulose film was taken out and washed with ethanol to remove the silicone oil. Then, the Ca-Alg gel in the bacterial cellulose film was dissolved using PBS. As a result, unexpectedly, some holes were formed in the bacterial cellulose film due to swelling of the Ca-Alg gel. This is thought to be due to the following reasons. When the bacterial cellulose film containing the Ca-Alg gel is immersed in ethanol, the ethanol penetrates into the bacterial cellulose film and comes into contact with the Ca-Alg gel. This causes the Ca-Alg gel to partially shrink and harden. When the bacterial cellulose film is then immersed in PBS, the hardened part of the Ca-Alg gel cannot dissolve in PBS, but absorbs PBS and swells. As a result, it is thought that holes are formed in the bacterial cellulose film.
[0110] On the other hand, when the bacterial cellulose film formed by culture in silicone oil was immersed in PBS, the Ca-Alg gel could be dissolved and removed without rapid swelling. As a result, no holes were formed in the bacterial cellulose film. In addition, the silicone oil attached to the surface of the bacterial cellulose film was lifted by PBS, and the silicone oil could be separated from the bacterial cellulose film.
[0111] These results suggest that it is preferable to remove the Ca-Alg gel from the bacterial cellulose membrane after incubation with silicone oil and before washing with ethanol. It also suggests that the ethanol washing step for removing silicone oil can be omitted.
[0112] [Example 2] <Preparation of bacterial cellulose membrane capsules encapsulating cosmetic glitter> Bacterial cellulose membrane capsules encapsulating cosmetic glitter (0.3-0.5 mm in diameter) were prepared by varying the incubation period in silicone oil in method A. When the incubation period in silicone oil was 6 days or less, holes were sometimes formed in the bacterial cellulose membrane during dissolution of the Ca-Alg gel by PBS. When the incubation period in silicone oil was 7 days or more, no holes were formed in the bacterial cellulose membrane, and bacterial cellulose membrane capsules encapsulating cosmetic glitter could be prepared. The bacterial cellulose membrane had a non-uniform thickness.
[0113] Next, bacterial cellulose membrane capsules encapsulating cosmetic glitter were prepared by changing the culture period in method A using HS medium containing three times the amount of D-glucose (9 w / v% D-glucose) instead of HS medium. Note that on the third day after the start of culture in silicone oil, the Ca-Alg gel with the attached cell suspension in each well was turned upside down. Culture in silicone oil was carried out for a total of seven days. This method allowed the preparation of bacterial cellulose membrane capsules encapsulating cosmetic glitter. Furthermore, the thickness of the bacterial cellulose membrane was almost uniform. (Figure 5).
[0114] [Example 3] <Preparation of bacterial cellulose membrane capsules encapsulating fluorescent particles> 2 mL of a 0.5 wt% Na-Alg aqueous solution containing 0.1 w / v% fluorescent particle (diameter 5.0 to 5.9 μm) solution was prepared. Using this 0.5 wt% Na-Alg aqueous solution, bacterial cellulose membrane capsules encapsulating fluorescent particles were prepared by method B. Figure 6(A) is an optical micrograph of Ca-Alg prepared by this method. Figure 6(B) is a fluorescent micrograph of Ca-Alg gel prepared by this method. As shown in Figure 6(B), fluorescent particles were present in the Ca-Alg gel. In method B, the Ca-Alg gel prepared is usually smaller than that in method A. Therefore, it is necessary to accurately collect a minute amount of Na-Alg aqueous solution using a micropipette or the like. For this reason, it is more suitable to use a lower concentration of Na-Alg aqueous solution than in method A. On the other hand, if the concentration of the Na-Alg aqueous solution is too low, the gel may become too small, as in the case of 10 wt% CaCl 2 When the solution was dropped into the aqueous solution, no gel particles were formed. From the viewpoints of ease of collection of the aqueous Na-Alg solution and gel particle formability, it was considered that the concentration of the aqueous Na-Alg solution in method B was preferably 0.5 wt%.
[0115] Figure 7 shows bacterial cellulose membrane capsules encapsulating fluorescent particles obtained by this method. The diameter of the bacterial cellulose membrane capsules was 2.9 mm (r = 0.145 cm), and the droplet size was 10 μL (droplet volume = 10 μL = 1.0 × 10 -3 cm 3 =4 / 3πr 3 :r=0.134cm), which was almost consistent with the results shown in Fig. 7. The scale bar in Fig. 7 indicates 300 μm. As shown in Fig. 7, when Ca-Alg gel not encapsulating fluorescent particles was used, no fluorescence was detected in the bacterial cellulose membrane. On the other hand, when Ca-Alg gel encapsulating fluorescent particles was used, fluorescent particles were observed in the bacterial cellulose membrane capsules.
[0116] (Investigation of bacterial cellulose membrane permeability of fluorescent particles) Bacterial cellulose capsules containing fluorescent particles were immersed in Milli-Q water for at least two weeks to confirm whether the fluorescent particles leaked out of the bacterial cellulose capsules. Bacterial cellulose capsules without fluorescent particles were immersed in a 0.01 w / v% fluorescent particle solution for 24 hours to confirm whether the fluorescent particles migrated into the bacterial cellulose capsules. The results are shown in Figure 8. Fluorescence microscopy showed that even when bacterial cellulose membrane capsules containing fluorescent particles were immersed in Milli-Q water, no leakage of fluorescent particles from the bacterial cellulose membrane capsules was observed (Figure 8(B)). The fluorescent particles were present near the inner surface of the bacterial cellulose membrane. On the other hand, even when bacterial cellulose membrane capsules not encapsulating fluorescent particles were immersed in a fluorescent particle solution, no migration of fluorescent particles into the bacterial cellulose membrane was observed (Figure 8(A)). The fluorescent particles were attached to the outer surface of the bacterial cellulose membrane. These results confirmed that particles larger than the pore size of the cellulose nanofiber network structure cannot pass through the bacterial cellulose membrane.
[0117] [Example 4] <Preparation of bacterial cellulose membrane capsules containing activated carbon (1)> Activated carbon-encapsulated bacterial cellulose membrane capsules were prepared by method A using activated carbon (diameter 0.3-0.8 mm) as particles. Figure 9(A) shows an optical microscope photograph of the activated carbon-encapsulated bacterial cellulose membrane capsules. As shown in Figure 9(A), it was confirmed that activated carbon was present in the internal space of the bacterial cellulose membrane.
[0118] [Example 5] <Preparation of bacterial cellulose membrane capsules containing activated carbon (2)> 2 mL of 0.5 wt% Na-Alg aqueous solution containing 0.1 w / v% activated carbon particle (diameter 6.0 μm) solution was prepared. This 0.5 wt% Na-Alg aqueous solution was used to prepare bacterial cellulose membrane capsules containing activated carbon particles by method A. Figure 9(B) shows an optical microscope photograph of the bacterial cellulose membrane capsules containing activated carbon. As shown in Figure 9(B), it was confirmed that activated carbon was present in the internal space of the bacterial cellulose membrane.
[0119] (Indole adsorption test) Three bacterial cellulose membrane capsules containing activated carbon (diameter 6.0 μm) or three bacterial cellulose membrane capsules containing nothing were placed in 3 mL of an indole aqueous solution (7.6 μg / mL), and the spectrum was measured over time at 37°C using a UV-visible spectrometer (V-530: JASCO). The indole concentration of the aqueous solution was measured from a calibration curve created from the absorbance at 279 nm.
[0120] The results are shown in Figure 10. In the bacterial cellulose membrane capsules containing nothing (blank), the indole concentration did not change over time. On the other hand, in the bacterial cellulose membrane capsules containing activated carbon, the indole concentration decreased over time. In the bacterial cellulose membrane capsules containing activated carbon, the indole concentration after 24 hours was 4.73 μg / mL. From these results, the amount of indole adsorbed per bacterial cellulose membrane capsule containing activated carbon was calculated to be 2.8 μg.
[0121] Figure 11 is a schematic diagram showing the adsorption mechanism of uremia causative substances by bacterial cellulose membrane capsules containing activated carbon. The bacterial cellulose membrane has a mesh structure made of nanofibers. Particles smaller than the pores of the mesh can pass through the bacterial cellulose membrane, but particles larger than the pores of the mesh cannot pass through the gel membrane. Indole, one of the causative substances of uremia, can pass through the bacterial cellulose membrane. Indole that has passed through the bacterial cellulose membrane is adsorbed by activated carbon contained in the bacterial cellulose membrane capsule. Since activated carbon cannot pass through the bacterial cellulose membrane, indole adsorbed by activated carbon is not released outside the bacterial cellulose membrane capsule. Therefore, the bacterial cellulose membrane capsules containing activated carbon can be used as a drug for treating uremia.
[0122] [Example 6] <Preparation of bacterial cellulose membrane capsules containing potassium adsorbent> 2 mL of 2 wt% aqueous agar solution containing 1.0 wt% potassium adsorbent (ion exchange resin: potassium polystyrene sulfonate with particle size of 5 μm or more) was prepared. This 2 wt% aqueous agar solution was used to prepare bacterial cellulose membrane capsules containing potassium adsorbent by method A. Figure 12 shows a photograph of the bacterial cellulose membrane capsules containing potassium adsorbent. As shown in Figure 12, it was confirmed that the potassium adsorbent was present in the internal space of the bacterial cellulose membrane.
[0123] [Example 7] <Preparation of bacterial cellulose membrane capsules encapsulating enzyme-immobilized beads> Horseradish peroxidase-immobilized chitosan beads were prepared according to a previous report (Kensuke Sakurai, Kazuyuki Kitada, Toshiyoshi Takahashi, "Preparation of chitosan beads and enzyme immobilization", Research Report of the Faculty of Engineering, Fukui University, 1989, 37(2), 173-182.) The chitosan beads are crosslinked with gluteraldehyde, so they do not dissolve in PBS and are retained within bacterial cellulose membrane capsules. Next, 2 mL of a 1.0 wt% Na-Alg aqueous solution containing 100 mg of the chitosan beads was prepared. This 1.0 wt% Na-Alg aqueous solution was used to prepare bacterial cellulose membrane capsules containing peroxidase-immobilized alginate beads by method A. Figure 13 shows a photograph of the bacterial cellulose membrane capsules containing peroxidase-immobilized chitosan beads. As shown in Figure 13, it was confirmed that peroxidase-immobilized chitosan beads were present in the internal space of the bacterial cellulose membrane.
[0124] (Enzyme activity test) To one bacterial cellulose membrane capsule containing peroxidase-immobilized chitosan beads, 1.0 mL of tetramethylbenzidine / acetic acid buffer (1.0 mg / mL) and 10 μL of hydrogen peroxide (30 w / v%) were added. As the enzyme reaction by peroxidase proceeds, tetramethylbenzidine is oxidized to form a dimer that exhibits a blue-green color and has an absorption maximum at 655 nm. The progress of the enzyme reaction was confirmed by visual observation.
[0125] The results are shown in Figure 13. It was confirmed that the bacterial cellulose membrane capsules encapsulating peroxidase-immobilized chitosan beads exhibited a blue-green color as the enzyme reaction progressed.
[0126] FIG. 13 is a schematic diagram showing the progress of the enzyme-substrate reaction in a bacterial cellulose membrane capsule encapsulating enzyme-immobilized beads. The enzyme-immobilized beads cannot permeate the bacterial cellulose membrane and are therefore retained within the bacterial cellulose membrane capsule. When the enzyme substrate is a low molecular weight substance that can permeate the bacterial cellulose membrane, it permeates the bacterial cellulose membrane and comes into contact with the enzyme-immobilized beads encapsulated in the bacterial cellulose membrane capsule. This allows the enzyme-substrate reaction to proceed within the bacterial cellulose membrane capsule. The reaction product of the enzyme-substrate reaction produced within the bacterial cellulose membrane capsule diffuses to the outside of the bacterial cellulose membrane capsule due to the concentration gradient between the inside and outside of the bacterial cellulose membrane capsule.
[0127] In vivo, immune cells cannot penetrate bacterial cellulose membranes, so enzyme-immobilized beads are protected from immune cells. In addition, by immobilizing multiple molecules with high binding affinity to each other on separate beads and encapsulating them in bacterial cellulose membranes, these molecules can coexist in an active state, enabling multi-step processes and rapid component separation. [Industrial Applicability]
[0128] According to the present invention, there are provided a method for producing a bacterial cellulose membrane capsule capable of encapsulating particles having a particle size of 1 μm or more, a bacterial cellulose membrane capsule produced by said method, and a pharmaceutical composition containing said bacterial cellulose membrane capsule. [Explanation of symbols]
[0129] 10...gelation-inducing liquid, 20...particulate gel, 21...gel, 22...target particles, 30...culture medium, 31...spherical bacterial cellulose membrane, 40...96-well microplate, 41...well, 50...hydrophobic medium, 60...solvent, 61...liquid, C1, C2...bacterial cellulose membrane capsule, D1, D2...culture droplets.
Claims
1. A step A of preparing a granular gel containing particles having a particle size of 1 μm or more; A step B of preparing a culture droplet of a cellulose-producing fungus containing the particulate gel; A step C of culturing the culture droplet in a hydrophobic medium and forming a bacterial cellulose film at the interface between the culture droplet and the hydrophobic medium to obtain a spherical bacterial cellulose film encapsulating the particulate gel; A step D of dissolving the particulate gel encapsulated in the spherical bacterial cellulose film; A method for producing a bacterial cellulose membrane capsule, comprising:
2. The method for producing a bacterial cellulose membrane capsule according to claim 1 , further comprising a step E of removing the hydrophobic medium from the spherical bacterial cellulose membrane.
3. The method for producing a bacterial cellulose membrane capsule according to claim 1 or 2, further comprising a step F of removing the cellulose-producing bacteria from the spherical bacterial cellulose membrane.
4. A hollow spherical bacterial cellulose membrane, A bacterial cellulose membrane capsule comprising: The bacterial cellulose membrane capsule has only one internal space partitioned from an external space by the hollow spherical bacterial cellulose membrane, The particles are present in the internal space. Bacterial cellulose membrane capsule.
5. The bacterial cellulose membrane capsule according to claim 4, wherein the particles having a diameter of 1 μm or more are selected from the group consisting of adsorbents and enzyme immobilization carriers.
6. A pharmaceutical composition comprising the bacterial cellulose membrane capsule according to claim 4 or 5.
7. 6. A pharmaceutical composition for treating or preventing uremia, comprising the bacterial cellulose membrane capsule according to claim 5, wherein the particles having a diameter of 1 μm or more are activated carbon.
8. A pharmaceutical composition for treating or preventing hyperkalemia, comprising the bacterial cellulose membrane capsule according to claim 5, wherein the particles having a diameter of 1 μm or more are a potassium adsorbent.
9. 6. A pharmaceutical composition for treating or preventing an enzyme deficiency comprising the bacterial cellulose membrane capsule according to claim 5, wherein the particles having a particle size of 1 μm or more are enzyme immobilized carriers.
Citation Information
Patent Citations
Method of producing bacterial cellulose
JP2014121314A
